Developer docs
API playgroundTry for free, no card

Search company profiles

Minerva Biolabs

Full company profile

uuid000y1sl

Namestring
Minerva Biolabs
Legal namestring
Minerva Biolabs GmbH
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Minerva Biolabs GmbH is a Berlin-based contamination detection and control company specializing in PCR-based mycoplasma and bacterial testing for the biopharmaceutical and cell therapy industries. The company sells a catalog of more than 40 products organized around three pillars: detection kits (the Venor®GeM family, Venor® Mycoplasma qPCR and dPCR, the NAT-MAT® integrated platform, and the MiQuant® dPCR line for AAV and CAR-T applications), regulatory reference standards (10CFU®, 100CFU®, and 100GC® Mycoplasma Standards designed for EP 2.6.7, USP <77>, and JP 18 G3 compliance), and decontamination and elimination reagents (PCR Clean™, Mycoplasma Off™, Mynox®, WaterShield™, ZellShield®). The underlying technology is proprietary PCR, qPCR, and dPCR chemistry with claimed sensitivity at the 10 CFU detection threshold for NAT-based mycoplasma testing.

The commercial model is product-led and transactional: products are priced individually at €22–€690 per unit and ordered via telephone, email, or a dedicated US storefront (minervabiolabs.us), supplemented by an actively recruited global distributor network. Target customer segments are pharma and biopharmaceutical companies, ATMP (cell and gene therapy) manufacturers, cell culture laboratories, and molecular biology / PCR laboratories, with regulatory compliance as the central value proposition. Beyond consumables, the firm operates an annual international Proficiency Testing Program (€295 per participation) that enables inter-laboratory comparison for NAT-based mycoplasma detection across multiple commercial kit platforms.

Operationally, Minerva Biolabs is small (1–10 employees), privately held, and bootstrapped — no venture capital, private equity, or parent company ownership is disclosed in available source material. Distribution is hybrid, combining direct telephone and email sales in Europe with distributor-led international reach, and the firm maintains a recurring trade fair presence at events including ISCT Asia, the PDA Pharmaceutical Microbiology Conference, analytica Shanghai, PharmaLab Darmstadt, and CellBio San Diego.

Short descriptiontext

Minerva Biolabs GmbH is a Berlin-based life sciences company selling PCR-based mycoplasma and bacterial detection kits, pharmacopoeia-compliant reference standards, and decontamination reagents to biopharmaceutical manufacturers, ATMP producers, and cell culture laboratories worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mycoplasma detection kits, PCR contamination testing, biopharmaceutical quality control, cell culture contamination control, molecular biology reagents
Industry3 codes
PRIMARYHLAGADAE
Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility)
SECONDARYHLAAACAK
Gene Therapy Analytical Testing & QC (potency, vg/ddPCR, infectivity, RCL/RCA)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Molecular Biology Reagents
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Detection Kits and Assays
TypeOne Time License
Description

Sale of PCR-based mycoplasma and bacteria detection kits including Venor®GeM product line variants (Classic, OneStep, qEP, qOneStep, Advance). Revenue generated through direct product sales and distributor channels.

minerva-biolabs.com
2Reference Standards and Controls
TypeOne Time License
Description

Sale of 10CFU®, 100CFU®, and 100GC® mycoplasma standards used as external positive controls and for validation of detection methods.

minerva-biolabs.com
3Proficiency Testing Program
TypeOne Time License
Description

Annual international proficiency testing program for contamination diagnostics. Costs €295 per participation for sample material production, logistics, and evaluation.

minerva-biolabs.com
4Decontamination Reagents
TypeOne Time License
Description

Sale of DNA/RNA decontamination products including PCR Clean™, PCR Clean™ Wipes, Mycoplasma Off™, Mycoplasma Off™ Wipes, and WaterShield™.

minerva-biolabs.com
5PCR Enzymes and Reagents
TypeOne Time License
Description

MB Taq Polymerase and other PCR reagents for molecular biology applications.

minerva-biolabs.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Pricing details10 tiers
1PCR Clean™ (250ml spray bottle)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€22.00 per unit

minerva-biolabs.com
2Venor® Mycoplasma Extraction
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€123.00 per unit

minerva-biolabs.com
3Venor®GeM qEP
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€377.00 per unit

minerva-biolabs.com
410CFU® Mycoplasma Standards
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€322.00-€429.00 depending on species

minerva-biolabs.com
5100CFU® Mycoplasma Standards
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€690.00 depending on species

minerva-biolabs.com
6100GC® Mycoplasma Standards
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€390.00 depending on species

minerva-biolabs.com
7Venor®GeM Classic (25 reactions)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€166.00

minerva-biolabs.com
8Venor®GeM OneStep (25 reactions)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€179.00

minerva-biolabs.com
9MB Taq Polymerase (50 units)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€50.00

minerva-biolabs.com
10Proficiency Testing Program 2026
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€295 per participation (includes sample material, logistics, evaluation, and documentation). Shipping costs: €18.60 for Germany, individual calculation for other countries.

minerva-biolabs.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Venor®
Description

Mycoplasma detection kit product line including Venor®GeM, Venor®Mycoplasma qPCR, Venor®Mycoplasma dPCR, and related extraction products.

minerva-biolabs.com
+5 more records
Core offering1 text field

Minerva Biolabs develops, manufactures, and sells molecular contamination detection and control products for cell culture, biopharmaceutical, and ATMP applications. Its core offerings include PCR, qPCR, and dPCR-based mycoplasma detection kits (Venor®GeM family), inactivated reference standards (10CFU®, 100CFU®, 100GC®) for pharmacopoeia-compliant validation, and DNA/mycoplasma decontamination reagents (PCR Clean™, Mycoplasma Off™, Mynox®), supplemented by an annual international Proficiency Testing Program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Mycoplasma detection in less than 3 hours using Venor® Bacteria qPCR
+1 more record
Product overview1 text field

Minerva Biolabs is a contamination detection and control company offering a comprehensive portfolio of PCR-based detection kits, reference standards, decontamination reagents, and sample preparation products for biopharmaceutical, cell culture, and ATMP manufacturing. The product range centers on mycoplasma and bacterial contamination control with the Venor®GeM family of detection kits (Classic, OneStep, qEP, qOneStep, Advance), complemented by 10CFU®, 100CFU®, and 100GC® Mycoplasma Standards for regulatory compliance (EP 2.6.7, USP <77>, JP 18 G3), and digital PCR solutions (Venor® Mycoplasma dPCR, MiQuant® product line). The portfolio also includes elimination products (Mycoplasma Off™, Mynox®, Mynox® Gold), decontamination reagents (PCR Clean™, WaterShield™, ZellShield®), and supporting services such as the annual Proficiency Testing Program for international laboratory comparison.

Product and service26 records
1Venor®GeM Classic
CategoryDetection Kit
Description

PCR-based mycoplasma detection kit for routine contamination screening of cell cultures and biologicals. Priced at €166 per 25 reactions.

2Venor®GeM OneStep
CategoryDetection Kit
Description

One-step PCR-based mycoplasma detection kit designed for rapid screening of mycoplasma contamination, priced at €179 per 25 reactions.

3Venor®GeM qEP
CategoryDetection Kit
Description

Quantitative real-time PCR kit for enhanced performance mycoplasma detection, priced at €377 per unit.

4Venor®GeM qOneStep
CategoryDetection Kit
Description

One-step quantitative real-time PCR mycoplasma detection kit for rapid quantitative screening.

5Venor®GeM Advance
CategoryDetection Kit
Description

Advanced PCR-based mycoplasma detection kit offering enhanced performance for regulatory-compliant testing.

6Venor® Mycoplasma qPCR
CategoryDetection Kit
Description

Real-time PCR-based detection kit for quantitative mycoplasma contamination screening in cell cultures and biologicals.

7Venor® Mycoplasma dPCR
CategoryDetection Kit
Description

Digital PCR-based detection kit providing highly sensitive mycoplasma detection for regulatory compliance.

8Venor® Bacteria qPCR
CategoryDetection Kit
Description

qPCR-based detection kit for bacterial contamination screening in cell cultures and biologicals, delivering results in less than 3 hours.

9Venor® Mycoplasma Extraction
CategorySample Preparation
Description

DNA/RNA extraction kit for mycoplasma sample preparation prior to PCR detection, priced at €123 per unit.

10Venor®GeM Sample Preparation Kit
CategorySample Preparation
Description

Sample preparation kit for mycoplasma detection workflows supporting Venor®GeM assays.

1110CFU® Mycoplasma Standards
CategoryStandards & Reference Material
Description

Inactivated, non-infectious mycoplasma standards for external positive controls in PCR-based mycoplasma testing, compliant with EP 2.6.7, USP <77>, and JP 18 G3. Available for multiple species at €322–€429.

12100CFU® Mycoplasma Standards
CategoryStandards & Reference Material
Description

Non-infectious, inactivated mycoplasma reference standards for NAT-based mycoplasma testing of biopharmaceuticals, cell culture-derived products, and ATMPs. Priced around €690 depending on species.

13100GC® Mycoplasma Standards
CategoryStandards & Reference Material
Description

Purified nucleic acid standards with defined genome copy numbers for product-specific validation of PCR-based mycoplasma testing methods, compliant with EP 2.6.7 (12.2) and USP <77>. Priced around €390.

14100CFU® Sensitivity Standards
CategoryStandards & Reference Material
Description

Reference materials for determining the limit of detection and for performance verification of PCR-based mycoplasma assays, complementary to 10CFU® Sensitivity Standards for matrix validation.

15PCR Clean™
CategoryDecontamination Reagent
Description

DNA decontamination reagent effective against amplicon, plasmid, or genomic DNA and RNA from most laboratory surfaces, priced at €22 per 250 ml spray bottle.

16PCR Clean™ Wipes
CategoryDecontamination Reagent
Description

Pre-moistened wipes for DNA decontamination of laboratory surfaces and equipment.

17Mycoplasma Off™
CategoryElimination Reagent
Description

Mycoplasma elimination reagent for decontamination of cell cultures affected by mycoplasma contamination.

18Mycoplasma Off™ Wipes
CategoryElimination Reagent
Description

Pre-moistened wipes for mycoplasma elimination from laboratory surfaces.

19Mynox®
CategoryElimination Reagent
Description

Mycoplasma elimination reagent for routine decontamination of contaminated cell cultures.

20Mynox® Gold
CategoryElimination Reagent
Description

Enhanced formulation mycoplasma elimination reagent for cell culture decontamination.

21MB Taq Polymerase
CategoryEnzyme
Description

Taq DNA polymerase enzyme for PCR applications in molecular biology workflows, priced at €50 per 50 units.

22MiQuant® AAV ITR 2/6 – dPCR
CategoryDetection Kit
Description

Digital PCR kit for detection of AAV inverted terminal repeats (ITR) 2/6 supporting gene therapy vector characterization.

23MiQuant® AAV ITR 5 – dPCR
CategoryDetection Kit
Description

Digital PCR kit for detection of AAV inverted terminal repeat (ITR) 5 supporting gene therapy vector characterization.

24MiQuant® CAR-T Cell Lenti – dPCR
CategoryDetection Kit
Description

Digital PCR kit for CAR-T cell and lentiviral vector detection in cell therapy manufacturing.

25MiQuant® Residual DNA HEK-293 – dPCR
CategoryDetection Kit
Description

Digital PCR kit for residual DNA detection in HEK-293 cell substrates used in biomanufacturing.

26Proficiency Testing Program 2026
CategoryService
Description

Annual international proficiency testing program for contamination diagnostics in cell cultures and biologicals. Participants receive sample sets, submit results, and obtain certificates of participation. Priced at €295 per participation, plus shipping. Supports inter-laboratory comparison using PCR kits from Minerva Biolabs, Sartorius Stedim, and QIAGEN.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or Integration
Description

Sartorius Stedim is explicitly mentioned as one of the approved PCR kit manufacturers whose products can be used in Minerva Biolabs' proficiency testing program alongside their own Venor®GeM products. The proficiency testing program validates NAT-based detection of mycoplasmas using commercially available kits from Sartorius Stedim, QIAGEN, and Minerva Biolabs.

Strategic tierCoreTypeTechnology or Integration
Description

QIAGEN is explicitly mentioned as one of the approved PCR kit manufacturers whose products (specifically QIAcuity Mycoplasma Quant) can be used in Minerva Biolabs' proficiency testing program. The program enables inter-laboratory comparison for users of QIAGEN mycoplasma detection kits alongside Minerva Biolabs products.

3Global Distributors
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Minerva Biolabs maintains a network of global distributors to serve customers worldwide. The company actively recruits new distributors and provides information about becoming a distributor through their website. Distributors benefit from distributing contamination control products in their respective countries.

minerva-biolabs.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Eurofins BioPharma Product Testing offers mycoplasma testing services (including PCR/NAT) as part of its contract lab portfolio, partially overlapping with Minerva's proficiency testing service and kit customer base.

TypeBroad incumbent
Description

Lonza provides cell and gene therapy manufacturing services including mycoplasma and sterility testing solutions, serving overlapping biopharma and ATMP customers as a broader bioprocess incumbent.

TypeBroad incumbent
Description

Roche operates a much larger diagnostics portfolio including PCR-based kits and qPCR/dPCR platforms used in pharma QC, serving as a broad incumbent that can bundle contamination control with broader offerings.

TypeBroad incumbent
Description

Promega supplies molecular biology reagents, PCR enzymes, and nucleic acid extraction kits that overlap with Minerva's MB Taq Polymerase, sample preparation, and decontamination products for the same PCR laboratory users.

TypeDirect peer
Description

Bio-Rad offers mycoplasma detection kits and digital PCR platforms (QXDx, ddPCR) that overlap with Minerva's Venor dPCR and MiQuant dPCR product families for biopharma analytics.

TypeEmerging player
Description

Charles River's Biologics Testing Services include mycoplasma contamination testing under GMP, serving the same biopharma and ATMP QC customers that buy Minerva's PCR kits and standards.

TypeDirect peer
Description

Thermo Fisher's MycoSEQ Mycoplasma Detection Kit and Pharmacogenomics offering compete head-on with Minerva's Venor product line in biopharmaceutical quality control labs.

TypeDirect peer
Description

QIAGEN sells the QIAcuity Mycoplasma Quant digital PCR kit and is named alongside Minerva in the same Proficiency Testing Program, overlapping directly on PCR-based mycoplasma detection consumables.

9Merck KGaA (MilliporeSigma)
TypeDirect peer
Description

Merck sells the MycoTOOL Mycoplasma Detection Kit and a broad portfolio of bioprocess contamination control products that directly compete with Minerva's Venor kits and standards.

TypeDirect peer
Description

Sartorius offers NAT-based mycoplasma detection kits used in cell-based bioprocesses and is explicitly named alongside Minerva in the same Proficiency Testing Program, making it the closest direct peer in contamination control.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Minerva Biolabs

Molecular Biology Reagentsminerva-biolabs.com

Minerva Biolabs GmbH is a Berlin-based life sciences company selling PCR-based mycoplasma and bacterial detection kits, pharmacopoeia-compliant reference standards, and decontamination reagents to biopharmaceutical manufacturers, ATMP producers, and cell culture laboratories worldwide.

What Minerva Biolabs does

Minerva Biolabs GmbH is a Berlin-based contamination detection and control company specializing in PCR-based mycoplasma and bacterial testing for the biopharmaceutical and cell therapy industries. The company sells a catalog of more than 40 products organized around three pillars: detection kits (the Venor®GeM family, Venor® Mycoplasma qPCR and dPCR, the NAT-MAT® integrated platform, and the MiQuant® dPCR line for AAV and CAR-T applications), regulatory reference standards (10CFU®, 100CFU®, and 100GC® Mycoplasma Standards designed for EP 2.6.7, USP <77>, and JP 18 G3 compliance), and decontamination and elimination reagents (PCR Clean™, Mycoplasma Off™, Mynox®, WaterShield™, ZellShield®). The underlying technology is proprietary PCR, qPCR, and dPCR chemistry with claimed sensitivity at the 10 CFU detection threshold for NAT-based mycoplasma testing.

The commercial model is product-led and transactional: products are priced individually at €22–€690 per unit and ordered via telephone, email, or a dedicated US storefront (minervabiolabs.us), supplemented by an actively recruited global distributor network. Target customer segments are pharma and biopharmaceutical companies, ATMP (cell and gene therapy) manufacturers, cell culture laboratories, and molecular biology / PCR laboratories, with regulatory compliance as the central value proposition. Beyond consumables, the firm operates an annual international Proficiency Testing Program (€295 per participation) that enables inter-laboratory comparison for NAT-based mycoplasma detection across multiple commercial kit platforms.

Operationally, Minerva Biolabs is small (1–10 employees), privately held, and bootstrapped — no venture capital, private equity, or parent company ownership is disclosed in available source material. Distribution is hybrid, combining direct telephone and email sales in Europe with distributor-led international reach, and the firm maintains a recurring trade fair presence at events including ISCT Asia, the PDA Pharmaceutical Microbiology Conference, analytica Shanghai, PharmaLab Darmstadt, and CellBio San Diego.

Minerva Biolabs firmographics

Firmographics
Name
Minerva Biolabs
Legal name
Minerva Biolabs GmbH
Website
https://minerva-biolabs.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Minerva Biolabs GmbH is a Berlin-based life sciences company selling PCR-based mycoplasma and bacterial detection kits, pharmacopoeia-compliant reference standards, and decontamination reagents to biopharmaceutical manufacturers, ATMP producers, and cell culture laboratories worldwide.
Ownership category
akta.pro rank

Minerva Biolabs industry classification

Industry
Product category
Molecular Biology Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGADAE
Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility)
SECONDARYHLAAACAK
Gene Therapy Analytical Testing & QC (potency, vg/ddPCR, infectivity, RCL/RCA)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)

Keywords

  • Mycoplasma detection kits
  • PCR contamination testing
  • Biopharmaceutical quality control
  • Cell culture contamination control
  • Molecular biology reagents

Where Minerva Biolabs is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Minerva Biolabs business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Detection Kits and Assays: Sale of PCR-based mycoplasma and bacteria detection kits including Venor®GeM product line variants (Classic, OneStep, qEP, qOneStep, Advance). Revenue generated through direct product sales and distributor channels.
  2. Reference Standards and Controls: Sale of 10CFU®, 100CFU®, and 100GC® mycoplasma standards used as external positive controls and for validation of detection methods.
  3. Proficiency Testing Program: Annual international proficiency testing program for contamination diagnostics. Costs €295 per participation for sample material production, logistics, and evaluation.
  4. Decontamination Reagents: Sale of DNA/RNA decontamination products including PCR Clean™, PCR Clean™ Wipes, Mycoplasma Off™, Mycoplasma Off™ Wipes, and WaterShield™.
  5. PCR Enzymes and Reagents: MB Taq Polymerase and other PCR reagents for molecular biology applications.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPCR Clean™ (250ml spray bottle)
Unit PricingPay-as-you-goVenor® Mycoplasma Extraction
Unit PricingPay-as-you-goVenor®GeM qEP
Unit PricingPay-as-you-go10CFU® Mycoplasma Standards
Unit PricingPay-as-you-go100CFU® Mycoplasma Standards
Unit PricingPay-as-you-go100GC® Mycoplasma Standards
Unit PricingPay-as-you-goVenor®GeM Classic (25 reactions)
Unit PricingPay-as-you-goVenor®GeM OneStep (25 reactions)
Unit PricingPay-as-you-goMB Taq Polymerase (50 units)
Unit PricingPay-as-you-goProficiency Testing Program 2026

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Minerva Biolabs product offering

Product offering

Core offering

Minerva Biolabs develops, manufactures, and sells molecular contamination detection and control products for cell culture, biopharmaceutical, and ATMP applications. Its core offerings include PCR, qPCR, and dPCR-based mycoplasma detection kits (Venor®GeM family), inactivated reference standards (10CFU®, 100CFU®, 100GC®) for pharmacopoeia-compliant validation, and DNA/mycoplasma decontamination reagents (PCR Clean™, Mycoplasma Off™, Mynox®), supplemented by an annual international Proficiency Testing Program.

Product overview

Minerva Biolabs is a contamination detection and control company offering a comprehensive portfolio of PCR-based detection kits, reference standards, decontamination reagents, and sample preparation products for biopharmaceutical, cell culture, and ATMP manufacturing. The product range centers on mycoplasma and bacterial contamination control with the Venor®GeM family of detection kits (Classic, OneStep, qEP, qOneStep, Advance), complemented by 10CFU®, 100CFU®, and 100GC® Mycoplasma Standards for regulatory compliance (EP 2.6.7, USP <77>, JP 18 G3), and digital PCR solutions (Venor® Mycoplasma dPCR, MiQuant® product line). The portfolio also includes elimination products (Mycoplasma Off™, Mynox®, Mynox® Gold), decontamination reagents (PCR Clean™, WaterShield™, ZellShield®), and supporting services such as the annual Proficiency Testing Program for international laboratory comparison.

Differentiator

Problem solved

Functional benefit

Brands

  • Venor®: Mycoplasma detection kit product line including Venor®GeM, Venor®Mycoplasma qPCR, Venor®Mycoplasma dPCR, and related extraction products.
  • 100CFU®
  • 10CFU®
  • 100GC®
  • PCR Clean™
  • Mycoplasma Off™

Products and services

  • Venor®GeM Classic PCR-based mycoplasma detection kit for routine contamination screening of cell cultures and biologicals. Priced at €166 per 25 reactions.
  • Venor®GeM OneStep One-step PCR-based mycoplasma detection kit designed for rapid screening of mycoplasma contamination, priced at €179 per 25 reactions.
  • Venor®GeM qEP Quantitative real-time PCR kit for enhanced performance mycoplasma detection, priced at €377 per unit.
  • Venor®GeM qOneStep One-step quantitative real-time PCR mycoplasma detection kit for rapid quantitative screening.
  • Venor®GeM Advance Advanced PCR-based mycoplasma detection kit offering enhanced performance for regulatory-compliant testing.
  • Venor® Mycoplasma qPCR Real-time PCR-based detection kit for quantitative mycoplasma contamination screening in cell cultures and biologicals.
  • Venor® Mycoplasma dPCR Digital PCR-based detection kit providing highly sensitive mycoplasma detection for regulatory compliance.
  • Venor® Bacteria qPCR qPCR-based detection kit for bacterial contamination screening in cell cultures and biologicals, delivering results in less than 3 hours.
  • Venor® Mycoplasma Extraction DNA/RNA extraction kit for mycoplasma sample preparation prior to PCR detection, priced at €123 per unit.
  • Venor®GeM Sample Preparation Kit Sample preparation kit for mycoplasma detection workflows supporting Venor®GeM assays.
  • 10CFU® Mycoplasma Standards Inactivated, non-infectious mycoplasma standards for external positive controls in PCR-based mycoplasma testing, compliant with EP 2.6.7, USP <77>, and JP 18 G3. Available for multiple species at €322–€429.
  • 100CFU® Mycoplasma Standards Non-infectious, inactivated mycoplasma reference standards for NAT-based mycoplasma testing of biopharmaceuticals, cell culture-derived products, and ATMPs. Priced around €690 depending on species.
  • 100GC® Mycoplasma Standards Purified nucleic acid standards with defined genome copy numbers for product-specific validation of PCR-based mycoplasma testing methods, compliant with EP 2.6.7 (12.2) and USP <77>. Priced around €390.
  • 100CFU® Sensitivity Standards Reference materials for determining the limit of detection and for performance verification of PCR-based mycoplasma assays, complementary to 10CFU® Sensitivity Standards for matrix validation.
  • PCR Clean™ DNA decontamination reagent effective against amplicon, plasmid, or genomic DNA and RNA from most laboratory surfaces, priced at €22 per 250 ml spray bottle.
  • PCR Clean™ Wipes Pre-moistened wipes for DNA decontamination of laboratory surfaces and equipment.
  • Mycoplasma Off™ Mycoplasma elimination reagent for decontamination of cell cultures affected by mycoplasma contamination.
  • Mycoplasma Off™ Wipes Pre-moistened wipes for mycoplasma elimination from laboratory surfaces.
  • Mynox® Mycoplasma elimination reagent for routine decontamination of contaminated cell cultures.
  • Mynox® Gold Enhanced formulation mycoplasma elimination reagent for cell culture decontamination.
  • MB Taq Polymerase Taq DNA polymerase enzyme for PCR applications in molecular biology workflows, priced at €50 per 50 units.
  • MiQuant® AAV ITR 2/6 – dPCR Digital PCR kit for detection of AAV inverted terminal repeats (ITR) 2/6 supporting gene therapy vector characterization.
  • MiQuant® AAV ITR 5 – dPCR Digital PCR kit for detection of AAV inverted terminal repeat (ITR) 5 supporting gene therapy vector characterization.
  • MiQuant® CAR-T Cell Lenti – dPCR Digital PCR kit for CAR-T cell and lentiviral vector detection in cell therapy manufacturing.
  • MiQuant® Residual DNA HEK-293 – dPCR Digital PCR kit for residual DNA detection in HEK-293 cell substrates used in biomanufacturing.
  • Proficiency Testing Program 2026 Annual international proficiency testing program for contamination diagnostics in cell cultures and biologicals. Participants receive sample sets, submit results, and obtain certificates of participation. Priced at €295 per participation, plus shipping. Supports inter-laboratory comparison using PCR kits from Minerva Biolabs, Sartorius Stedim, and QIAGEN.

Quantifiable outcome

  • Mycoplasma detection in less than 3 hours using Venor® Bacteria qPCR
  • +1 more outcomes

Companies that use Minerva Biolabs

Customer profile

Segments4 records

Ideal customer profiles4 records

Minerva Biolabs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Minerva Biolabs partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Sartorius StedimcoreTechnology or IntegrationSartorius Stedim is explicitly mentioned as one of the approved PCR kit manufacturers whose products can be used in Minerva Biolabs' proficiency testing program alongside their own Venor®GeM products. The proficiency testing program validates NAT-based detection of mycoplasmas using commercially available kits from Sartorius Stedim, QIAGEN, and Minerva Biolabs.
  • QIAGENcoreTechnology or IntegrationQIAGEN is explicitly mentioned as one of the approved PCR kit manufacturers whose products (specifically QIAcuity Mycoplasma Quant) can be used in Minerva Biolabs' proficiency testing program. The program enables inter-laboratory comparison for users of QIAGEN mycoplasma detection kits alongside Minerva Biolabs products.
  • Global DistributorscoreChannel Partner/ Reseller/ DistributorMinerva Biolabs maintains a network of global distributors to serve customers worldwide. The company actively recruits new distributors and provides information about becoming a distributor through their website. Distributors benefit from distributing contamination control products in their respective countries.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Minerva Biolabs competitors and assessment

Company assessment

Emerging players

  • Eurofins Scientific: Eurofins BioPharma Product Testing offers mycoplasma testing services (including PCR/NAT) as part of its contract lab portfolio, partially overlapping with Minerva's proficiency testing service and kit customer base.
  • Charles River Laboratories: Charles River's Biologics Testing Services include mycoplasma contamination testing under GMP, serving the same biopharma and ATMP QC customers that buy Minerva's PCR kits and standards.

Broad incumbents

  • Lonza Group: Lonza provides cell and gene therapy manufacturing services including mycoplasma and sterility testing solutions, serving overlapping biopharma and ATMP customers as a broader bioprocess incumbent.
  • Roche Diagnostics: Roche operates a much larger diagnostics portfolio including PCR-based kits and qPCR/dPCR platforms used in pharma QC, serving as a broad incumbent that can bundle contamination control with broader offerings.
  • Promega Corporation: Promega supplies molecular biology reagents, PCR enzymes, and nucleic acid extraction kits that overlap with Minerva's MB Taq Polymerase, sample preparation, and decontamination products for the same PCR laboratory users.

Direct peers

  • Bio-Rad Laboratories: Bio-Rad offers mycoplasma detection kits and digital PCR platforms (QXDx, ddPCR) that overlap with Minerva's Venor dPCR and MiQuant dPCR product families for biopharma analytics.
  • Thermo Fisher Scientific: Thermo Fisher's MycoSEQ Mycoplasma Detection Kit and Pharmacogenomics offering compete head-on with Minerva's Venor product line in biopharmaceutical quality control labs.
  • QIAGEN: QIAGEN sells the QIAcuity Mycoplasma Quant digital PCR kit and is named alongside Minerva in the same Proficiency Testing Program, overlapping directly on PCR-based mycoplasma detection consumables.
  • Merck KGaA (MilliporeSigma): Merck sells the MycoTOOL Mycoplasma Detection Kit and a broad portfolio of bioprocess contamination control products that directly compete with Minerva's Venor kits and standards.
  • Sartorius (Stedim Biotech): Sartorius offers NAT-based mycoplasma detection kits used in cell-based bioprocesses and is explicitly named alongside Minerva in the same Proficiency Testing Program, making it the closest direct peer in contamination control.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Minerva Biolabs social profiles

Digital presence

Minerva Biolabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Minerva Biolabs leadership team

Management profile

Number of profiles

Profiles1 record

Minerva Biolabs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Minerva Biolabs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Minerva Biolabs

What does Minerva Biolabs do?

Minerva Biolabs develops, manufactures, and sells molecular contamination detection and control products for cell culture, biopharmaceutical, and ATMP applications. Its core offerings include PCR, qPCR, and dPCR-based mycoplasma detection kits (Venor®GeM family), inactivated reference standards (10CFU®, 100CFU®, 100GC®) for pharmacopoeia-compliant validation, and DNA/mycoplasma decontamination reagents (PCR Clean™, Mycoplasma Off™, Mynox®), supplemented by an annual international Proficiency Testing Program.

Is Minerva Biolabs a public or private company?

Minerva Biolabs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Minerva Biolabs founded?

Minerva Biolabs was founded in 2012. It employs 11 to 50 people.

Where is Minerva Biolabs based?

Minerva Biolabs is headquartered in Berlin, Germany, in the Europe region.

How does Minerva Biolabs make money?

Five revenue lines are on record. Detection Kits and Assays are the primary driver. The others are reference Standards and Controls, proficiency Testing Program, decontamination Reagents and PCR Enzymes and Reagents.

Who are Minerva Biolabs's main competitors?

Emerging players on record are Eurofins Scientific and Charles River Laboratories. Broad incumbents are Lonza Group, Roche Diagnostics and Promega Corporation. Direct peers are Bio-Rad Laboratories, Thermo Fisher Scientific, QIAGEN, Merck KGaA (MilliporeSigma) and Sartorius (Stedim Biotech).

Does Minerva Biolabs have an API?

No public API is recorded for Minerva Biolabs.

What industry is Minerva Biolabs in?

Minerva Biolabs's product category is Molecular Biology Reagents. Its primary akta.pro industry code is HLAGADAE, Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility), with a secondary code of HLAAACAK, Gene Therapy Analytical Testing & QC (potency, vg/ddPCR, infectivity, RCL/RCA). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales